Exact Mass: 646.3387

Abrusoside A

C36H54O10 (646.3717)

A triterpenoid saponin that is (22S,24Z)-3beta-hydroxy-26-oxo-22,26-epoxy-9beta,19-cyclolanost-24-en-28-oic acid having a beta-D-glucosyl residue attached at position 3 via a glycosidic bond.

Goshonoside F5

C32H54O13 (646.3564)

Goshonoside F5 is found in fruits. Goshonoside F5 is a constituent of Rubus foliolosus (Ceylon raspberry). Constituent of Rubus foliolosus (Ceylon raspberry). Goshonoside F5 is found in fruits.

Gypsogenin 3-O-b-D-glucuronide

C36H54O10 (646.3717)

Gypsogenin 3-O-b-D-glucuronide is found in fruits. Gypsogenin 3-O-b-D-glucuronide is a constituent of the famine food Momordica dioica. Constituent of the famine food Momordica dioica. Gypsogenin 3-O-b-D-glucuronide is found in fruits.

Lyciumoside VIII

C32H54O13 (646.3564)

Constituent of Lycium chinense (Chinese boxthorn). Lyciumoside VIII is found in tea, coffee and coffee products, and herbs and spices. Lyciumoside VIII is found in coffee and coffee products. Lyciumoside VIII is a constituent of Lycium chinense (Chinese boxthorn).

Monoglucuronylglycyrrhetinic acid

C36H54O10 (646.3717)

Monoglucuronylglycyrrhetinic acid is a sweetener about 940 times sweeter than sucrose. Sweetener ca. 940 times sweeter than sucrose Glycyrrhetic acid 3-O-β-D-glucuronide, isolated from glycyrrhiza, is an important derivative of glycyrrhizin (GL) with an anti -allergic activity[1]. Glycyrrhetic acid 3-O-β-D-glucuronide (GAMG) shows that β‐glucuronidases (β‐GUS) are key GAMG-producing enzymes, displaying a high potential to convert GL directly into GAMG[2].Glycyrrhetic acid 3-O-β-D-glucuronide is valuable as a sweetener. Glycyrrhetic acid 3-O-β-D-glucuronide, isolated from glycyrrhiza, is an important derivative of glycyrrhizin (GL) with an anti -allergic activity[1]. Glycyrrhetic acid 3-O-β-D-glucuronide (GAMG) shows that β‐glucuronidases (β‐GUS) are key GAMG-producing enzymes, displaying a high potential to convert GL directly into GAMG[2].Glycyrrhetic acid 3-O-β-D-glucuronide is valuable as a sweetener.

Z-Ile-Glu(OtBu)-Ala-Leu-CHO

C33H50N4O9 (646.3578)

PA(10:0/20:3(8Z,11Z,14Z)-2OH(5,6))

C33H59O10P (646.3846)

PA(10:0/20:3(8Z,11Z,14Z)-2OH(5,6)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(10:0/20:3(8Z,11Z,14Z)-2OH(5,6)), in particular, consists of one chain of one decanoyl at the C-1 position and one chain of 5,6-dihydroxyeicosatrienoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(20:3(8Z,11Z,14Z)-2OH(5,6)/10:0)

C33H59O10P (646.3846)

PA(20:3(8Z,11Z,14Z)-2OH(5,6)/10:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(20:3(8Z,11Z,14Z)-2OH(5,6)/10:0), in particular, consists of one chain of one 5,6-dihydroxyeicosatrienoyl at the C-1 position and one chain of decanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

gambogenic acid

C38H46O9 (646.3142)

3-MGA

C36H54O10 (646.3717)

Glycyrrhetic acid 3-O-glucuronide is a triterpenoid saponin that is the 3-O-beta-glucuronide of glycyrrhetic acid. It is a metabolite of glycyrrhizin contained in licorice and potentially a causative agent in the pathogenesis of pseudoaldosteronism. It has a role as an anti-allergic agent, a sweetening agent, an EC 1.1.1.146 (11beta-hydroxysteroid dehydrogenase) inhibitor, a human xenobiotic metabolite and a plant metabolite. It is a monosaccharide derivative, a beta-D-glucosiduronic acid, a triterpenoid saponin, a pentacyclic triterpenoid, an oxo dicarboxylic acid and an enone. It is functionally related to a glycyrrhetinic acid. A triterpenoid saponin that is the 3-O-beta-glucuronide of glycyrrhetic acid. It is a metabolite of glycyrrhizin contained in licorice and potentially a causative agent in the pathogenesis of pseudoaldosteronism. Glycyrrhetic acid 3-O-β-D-glucuronide, isolated from glycyrrhiza, is an important derivative of glycyrrhizin (GL) with an anti -allergic activity[1]. Glycyrrhetic acid 3-O-β-D-glucuronide (GAMG) shows that β‐glucuronidases (β‐GUS) are key GAMG-producing enzymes, displaying a high potential to convert GL directly into GAMG[2].Glycyrrhetic acid 3-O-β-D-glucuronide is valuable as a sweetener. Glycyrrhetic acid 3-O-β-D-glucuronide, isolated from glycyrrhiza, is an important derivative of glycyrrhizin (GL) with an anti -allergic activity[1]. Glycyrrhetic acid 3-O-β-D-glucuronide (GAMG) shows that β‐glucuronidases (β‐GUS) are key GAMG-producing enzymes, displaying a high potential to convert GL directly into GAMG[2].Glycyrrhetic acid 3-O-β-D-glucuronide is valuable as a sweetener.

Gypsogenin-3-O-glucuronide

C36H54O10 (646.3717)

6alpha-Acetoxy-9beta-benzoyloxy-1beta-cinnamoyloxy-8beta-(2-methylbutanoyloxy)-beta-dihydroagarofuran

C38H46O9 (646.3142)

Mezzettiaside 11

C32H54O13 (646.3564)

Gambogenific acid

C38H46O9 (646.3142)

Chondramide A

C36H46N4O7 (646.3366)

A chondramide that is chondramide C in which the pro-S hydrogen at position 2 of the beta-tyrosine residue is replaced by a methoxy group. It is produced by strains of the myxobacterium, Chondromyces crocatus.

Cussoside B

C32H54O13 (646.3564)

9S-10alpha-Hydroxyepigambogic acid

C38H46O9 (646.3142)

Garcinolic acid

C38H46O9 (646.3142)

SpecPlus_000070

C38H46O9 (646.3142)

(2Z)-4-[(5R*,16aS*)-3a,4,5,7,9,10,11,12,12a,13-decahydro-8,10-dihydroxy-3,3,10,13,13-pentamethyl-15-(3-methylbut-2-en-1-yl)-7,17-dioxo-3H,8bH-1,5-methanofuro[3,4-g]isochromeno[4,3-b]xanthen-1-yl]-2-methylbut-2-enoic acid|gambogefic acid A

C38H46O9 (646.3142)

xyloccensin I

C34H46O12 (646.2989)

mitrarioside B

C32H54O13 (646.3564)

microtropioside F

C32H54O13 (646.3564)

C36H42N2O9

C36H42N2O9 (646.289)

Cyasteron-2,3,22-triacetat

C35H50O11 (646.3353)

C36H54O10

C36H54O10 (646.3717)

Casearin C

C36H54O10 (646.3717)

gomojoside G

C32H54O13 (646.3564)

thyrsiferyl 18-acetate

C32H55BrO8 (646.308)

7alpha-acetoxy-14beta,15beta-epoxy-gedunan-1-ene-3-O-beta-D-glucopyranoside

C34H46O12 (646.2989)

3-Hydroxyaglaine C

C36H42N2O9 (646.289)

(3beta,5alpha,6alpha,15alpha,22E,24xi)-24-O-[4-Sulfato-beta-D-xylopyranoside]:Cholest-22-ene-3,6,15,24-tetrol

C32H54O11S (646.3387)

3-(12-methoxy-ibogamin-13-yl)-vobasan-17-oic acid methyl ester|Demethoxycarbonylvoacamin

C41H50N4O3 (646.3883)

C35H50O11

C35H50O11 (646.3353)

9R-10alpha-Hydroxyepigambogic acid

C38H46O9 (646.3142)

NSC680107

C35H50O11 (646.3353)

6-methylspinosyn beta

C36H54O10 (646.3717)

Neodarutoside

C32H54O13 (646.3564)

Isoaureosid

C32H54O13 (646.3564)

Aureosid

C32H54O13 (646.3564)

Ervafolidene

C40H46N4O4 (646.3519)

thyrsifenyl 23-acetate

C32H55BrO8 (646.308)

perviridisin B

C36H42N2O9 (646.289)

(3S,5S,10S,13R,16R,17S,20S,22R,23S,24S)-16,22-epoxy-21,23-lactone-24-hydroxy-3-O-beta-D-glucostigmasta-8,14-dien-28-one|vernoantheloside A

C35H50O11 (646.3353)

leuconoline

C40H46N4O4 (646.3519)

alphapolynin G

C34H46O12 (646.2989)

3beta-hydroxy-22-oxo-12-oleanen-29-oic acid 3-O-beta-D-glucuropyranoside|caraganin A

C36H54O10 (646.3717)

aphanamene A

C40H54O7 (646.3869)

nimbolinin C

C38H46O9 (646.3142)

Criophyllin

C40H46N4O4 (646.3519)

tabernaemontabovine

C41H50N4O3 (646.3883)

11alpha,12alpha-epoxy-3beta-[(O-beta-D-glucuronopyranosyl)oxy]olean-28,13-olide

C36H54O10 (646.3717)

decarbomethoxyvoacamine

C41H50N4O3 (646.3883)

Criophyllin|criophylline|ent-6alpha,7alpha-epoxy-8beta-(ent-6alpha,7alpha-epoxy-22-nor-vallesamidin-15-yl)-2,3-didehydro-aspidospermidine-3-carboxylic acid methyl ester

C40H46N4O4 (646.3519)

C39H50O8

C39H50O8 (646.3506)

gomojoside B

C32H54O13 (646.3564)

euplexide E

C35H50O11 (646.3353)

3beta-hydroxyursa-12,18-diene-24,28-dioic acid 28-O-beta-D-glucopyranoside|ilexhainanoside A

C36H54O10 (646.3717)

Glu Ser Gln Arg Gln

C24H42N10O11 (646.3034)

Arg Glu Ser Leu Glu

C26H46N8O11 (646.3286)

10α-Hydroxyepigambogic acid

C38H46O9 (646.3142)

8,8a-Dihydro-8-hydroxygambogic acid

C38H46O9 (646.3142)

C32H54O13_(2E)-5-{(1R,4aS,5S,6R,8aS)-5-[(beta-D-Glucopyranosyloxy)methyl]-6-hydroxy-5,8a-dimethyl-2-methylenedecahydro-1-naphthalenyl}-3-methyl-2-penten-1-yl beta-D-glucopyranoside

C32H54O13 (646.3564)

(2R,3R,4S,5S,6R)-2-[(E)-5-[(1R,4aS,5S,6R,8aS)-6-hydroxy-5,8a-dimethyl-2-methylidene-5-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]-3-methylpent-2-enoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C32H54O13 (646.3564)

Criophylline

C40H46N4O4 (646.3519)

(2R,3R,4S,5S,6R)-2-[(E)-5-[(1R,4aS,5S,6R,8aS)-6-hydroxy-5,8a-dimethyl-2-methylidene-5-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]-3-methylpent-2-enoxy]-6-(hydroxymethyl)oxane-3,4,5-triol_major

C32H54O13 (646.3564)

Lys Lys Trp Trp

C34H46N8O5 (646.3591)

Lys Gln Trp Trp

C33H42N8O6 (646.3227)

Lys Trp Lys Trp

C34H46N8O5 (646.3591)

Lys Trp Gln Trp

C33H42N8O6 (646.3227)

Lys Trp Trp Lys

C34H46N8O5 (646.3591)

Lys Trp Trp Gln

C33H42N8O6 (646.3227)

Gln Lys Trp Trp

C33H42N8O6 (646.3227)

Gln Trp Lys Trp

C33H42N8O6 (646.3227)

Gln Trp Trp Lys

C33H42N8O6 (646.3227)

Trp Lys Lys Trp

C34H46N8O5 (646.3591)

Trp Lys Gln Trp

C33H42N8O6 (646.3227)

Trp Lys Trp Lys

C34H46N8O5 (646.3591)

Trp Lys Trp Gln

C33H42N8O6 (646.3227)

Trp Gln Lys Trp

C33H42N8O6 (646.3227)

Trp Gln Trp Lys

C33H42N8O6 (646.3227)

Trp Trp Lys Lys

C34H46N8O5 (646.3591)

Trp Trp Lys Gln

C33H42N8O6 (646.3227)

Trp Trp Gln Lys

C33H42N8O6 (646.3227)

ESQRQ

C24H42N10O11 (646.3034)

WLKSN

C30H46N8O8 (646.3438)

YVRPL

C31H50N8O7 (646.3802)

Lyciumoside VIII

C32H54O13 (646.3564)

Vaccaroside

C36H54O10 (646.3717)

glycyrrhetyl 3-monoglucuronide

C36H54O10 (646.3717)

Glycyrrhetic acid 3-O-β-D-glucuronide, isolated from glycyrrhiza, is an important derivative of glycyrrhizin (GL) with an anti -allergic activity[1]. Glycyrrhetic acid 3-O-β-D-glucuronide (GAMG) shows that β‐glucuronidases (β‐GUS) are key GAMG-producing enzymes, displaying a high potential to convert GL directly into GAMG[2].Glycyrrhetic acid 3-O-β-D-glucuronide is valuable as a sweetener. Glycyrrhetic acid 3-O-β-D-glucuronide, isolated from glycyrrhiza, is an important derivative of glycyrrhizin (GL) with an anti -allergic activity[1]. Glycyrrhetic acid 3-O-β-D-glucuronide (GAMG) shows that β‐glucuronidases (β‐GUS) are key GAMG-producing enzymes, displaying a high potential to convert GL directly into GAMG[2].Glycyrrhetic acid 3-O-β-D-glucuronide is valuable as a sweetener.

Goshonoside F5

C32H54O13 (646.3564)

OHODA-PA

C33H59O10P (646.3846)

4-Methoxyphenyl-2,3,4,6-tetra-O-benzyl-β-D-galactopyranoside

C41H42O7 (646.293)

Thyrsiferyl 23-acetate

C32H55BrO8 (646.308)

(2E)-5-[(1R,4aS,5S,6R,8aS)-5-[(beta-D-Glucopyranosyloxy)methyl]decahydro-6-hydroxy-5,8a-dimethyl-2-methylene-1-naphthalenyl]-3-methyl-2-penten-1-yl beta-D-glucopyranoside

C32H54O13 (646.3564)

1-[1-Carboxy-3-[[3-carboxy-5-[3-[decanoyl(hydroxy)amino]propylamino]-3-hydroxy-5-oxopentanoyl]amino]propyl]-2-hydroxy-5-oxopyrrolidine-2-carboxylic acid

C28H46N4O13 (646.3061)

Cbz-DL-xiIle-DL-Glu(OtBu)-DL-Ala-DL-Leu-For

C33H50N4O9 (646.3578)

D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015853 - Cysteine Proteinase Inhibitors

PA(10:0/20:3(8Z,11Z,14Z)-2OH(5,6))

C33H59O10P (646.3846)

PA(20:3(8Z,11Z,14Z)-2OH(5,6)/10:0)

C33H59O10P (646.3846)

[(2R)-1-hydroxy-3-[hydroxy-[(2R,3R,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropan-2-yl] (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate

C31H51O12P (646.3118)

2-[2-[Bis(carboxymethyl)amino]ethyl-[2-[3-[4-(3,8-diamino-5-methylphenanthridin-5-ium-6-yl)anilino]propylamino]-2-oxoethyl]amino]acetic acid

C33H40N7O7+ (646.2989)

[2-hydroxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate

C31H51O12P (646.3118)

Smgdg O-20:5_2:0

C31H50O12S (646.3023)

Smgdg O-18:5_4:0

C31H50O12S (646.3023)

PMeOH 32:8

C36H55O8P (646.3634)

[1-[(2-heptanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C33H59O10P (646.3846)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C33H59O10P (646.3846)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-nonanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C33H59O10P (646.3846)

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-undecanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C33H59O10P (646.3846)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C33H59O10P (646.3846)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C33H59O10P (646.3846)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C33H59O10P (646.3846)

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C33H59O10P (646.3846)

[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-phosphonooxypropyl] (8E,11E,14E)-heptadeca-8,11,14-trienoate

C36H55O8P (646.3634)

[1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (9E,11E,13E)-hexadeca-9,11,13-trienoate

C33H59O10P (646.3846)

[1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-[(E)-undec-4-enoyl]oxypropan-2-yl] (4E,7E)-hexadeca-4,7-dienoate

C33H59O10P (646.3846)

(1S,3R,6S,7S,8R,11S,12S,16R)-7,12,16-Trimethyl-15-[(1S)-1-[(2S)-5-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-6-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentacyclo[9.7.0.01,3.03,8.012,16]octadecane-7-carboxylic acid

C36H54O10 (646.3717)

Monoglucuronylglycyrrhetinic acid

C36H54O10 (646.3717)

Glycyrrhetic acid 3-O-β-D-glucuronide, isolated from glycyrrhiza, is an important derivative of glycyrrhizin (GL) with an anti -allergic activity[1]. Glycyrrhetic acid 3-O-β-D-glucuronide (GAMG) shows that β‐glucuronidases (β‐GUS) are key GAMG-producing enzymes, displaying a high potential to convert GL directly into GAMG[2].Glycyrrhetic acid 3-O-β-D-glucuronide is valuable as a sweetener. Glycyrrhetic acid 3-O-β-D-glucuronide, isolated from glycyrrhiza, is an important derivative of glycyrrhizin (GL) with an anti -allergic activity[1]. Glycyrrhetic acid 3-O-β-D-glucuronide (GAMG) shows that β‐glucuronidases (β‐GUS) are key GAMG-producing enzymes, displaying a high potential to convert GL directly into GAMG[2].Glycyrrhetic acid 3-O-β-D-glucuronide is valuable as a sweetener.

phosphatidylserine 26:2(1-)

C32H57NO10P (646.372)

A 3-sn-phosphatidyl-L-serine(1-) in which the acyl groups at C-1 and C-2 contain 26 carbons in total and 2 double bonds.

SMGDG O-22:5

C31H50O12S (646.3023)

SQDG 22:4

C31H50O12S (646.3023)

DGMG 16:4

C31H50O14 (646.32)

SQMG 23:4

C32H54O11S (646.3387)

DGGA 26:7

C35H50O11 (646.3353)

MGGA 27:7

C36H54O10 (646.3717)

PA O-30:4;O3

C33H59O10P (646.3846)

PA P-18:0/12:3;O3

C33H59O10P (646.3846)

PA P-18:1/12:2;O3

C33H59O10P (646.3846)

PA 18:0/12:3;O2

C33H59O10P (646.3846)

PA 18:1/11:3;O3

C32H55O11P (646.3482)

PA 18:1/12:2;O2

C33H59O10P (646.3846)

PA 22:0/8:3;O2

C33H59O10P (646.3846)

PA 22:1/7:3;O3

C32H55O11P (646.3482)

PA 22:1/8:2;O2

C33H59O10P (646.3846)

PA 22:2/7:2;O3

C32H55O11P (646.3482)

PA 22:2/8:1;O2

C33H59O10P (646.3846)

PA 22:6/9:4;O2

C34H47O10P (646.2907)

PA 29:4;O3

C32H55O11P (646.3482)

PA 31:10;O2

C34H47O10P (646.2907)

LPGP 22:1

C28H56O12P2 (646.3247)

PG O-25:6;O3

C31H51O12P (646.3118)

PG O-26:5;O2

C32H55O11P (646.3482)

PG O-27:4;O

C33H59O10P (646.3846)

PG P-16:1/11:2;O

C33H59O10P (646.3846)

PG P-18:1/7:4;O3

C31H51O12P (646.3118)

PG P-18:1/8:3;O2

C32H55O11P (646.3482)

PG P-18:1/9:2;O

C33H59O10P (646.3846)

PG P-20:0/7:3;O

C33H59O10P (646.3846)

PG 14:1/12:3;O

C32H55O11P (646.3482)

PG 16:1/9:4;O2

C31H51O12P (646.3118)

PG 18:1/8:3;O

C32H55O11P (646.3482)

PG 18:2/7:3;O2

C31H51O12P (646.3118)

PG 18:3/7:2;O2

C31H51O12P (646.3118)

PG 18:3/8:1;O

C32H55O11P (646.3482)

PG 20:2/6:2;O

C32H55O11P (646.3482)

PG 20:4/5:1;O2

C31H51O12P (646.3118)

PG 25:5;O2

C31H51O12P (646.3118)

PG 26:4;O

C32H55O11P (646.3482)

LPI 22:5

C31H51O12P (646.3118)

PEth 31:8

C36H55O8P (646.3634)

PM 32:8

C36H55O8P (646.3634)

ST 25:1;O8;GlcA

C31H50O14 (646.32)

ST 26:0;O7;GlcA

C32H54O13 (646.3564)

ST 28:6;O6;GlcA

C34H46O12 (646.2989)

ST 29:5;O5;GlcA

C35H50O11 (646.3353)

ST 26:1;O8;Hex

C32H54O13 (646.3564)

ST 28:7;O7;Hex

C34H46O12 (646.2989)

ST 29:6;O6;Hex

C35H50O11 (646.3353)

[(2r,3s,4r,5r,6s)-3,4-bis(acetyloxy)-5-hydroxy-6-{4-hydroxy-2-[(2e,6e,9e)-11-methoxy-3,7,11-trimethyldodeca-2,6,9-trien-1-yl]-5-methylphenoxy}oxan-2-yl]methyl acetate

C35H50O11 (646.3353)

(1r,4s)-4-[(4as,6s,8ar)-6-[(2r)-5-bromo-2,6,6-trimethyloxan-2-yl]-8a-methyl-hexahydro-2h-pyrano[3,2-b]pyran-2-yl]-4-hydroxy-1-[(2r,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]pentyl acetate

C32H55BrO8 (646.308)

(2r,3r,4s,5s,6r)-2-{[(1r,4ar,5s,8s,8ar)-8-hydroxy-1,4a-dimethyl-5-[(3e)-3-methyl-5-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pent-3-en-1-yl]-6-methylidene-hexahydro-2h-naphthalen-1-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C32H54O13 (646.3564)

(3s,4s,7r,10s,13s,15e,17r,18r)-6,12-dihydroxy-4-(4-hydroxyphenyl)-7-(1h-indol-3-ylmethyl)-3-methoxy-8,10,13,15,17,18-hexamethyl-1-oxa-5,8,11-triazacyclooctadeca-5,11,15-triene-2,9-dione

C36H46N4O7 (646.3366)

(2s,3s,4s,5r,6r)-5-hydroxy-2-methyl-6-(octyloxy)-4-{[(2s,3r,4r,5s,6s)-3,4,5-tris(acetyloxy)-6-methyloxan-2-yl]oxy}oxan-3-yl hexanoate

C32H54O13 (646.3564)

(2s,3s,4s,5r,6r)-6-{[(3s,4s,4ar,6ar,6bs,8as,12as,14ar,14br)-8a-carboxy-4-formyl-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C36H54O10 (646.3717)

17-(acetyloxy)-8-(furan-3-yl)-12-hydroxy-4-methoxy-1,9,11,16-tetramethyl-5,14-dioxapentacyclo[11.6.1.0²,¹¹.0⁶,¹⁰.0¹⁶,²⁰]icos-9-en-19-yl 3-phenylprop-2-enoate

C38H46O9 (646.3142)

(1r,2r,3as,3bs,9br,11ar)-1-[(2r,4e)-2,3-dihydroxy-6-methylhepta-4,6-dien-2-yl]-2,7-dihydroxy-3a,6,9b,11a-tetramethyl-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,5h,11h-cyclopenta[a]phenanthren-10-one

C35H50O11 (646.3353)

6-({6,10,10,14,15,21,21-heptamethyl-25-oxo-3,24-dioxaheptacyclo[16.5.2.0¹,¹⁵.0²,⁴.0⁵,¹⁴.0⁶,¹¹.0¹⁸,²³]pentacosan-9-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C36H54O10 (646.3717)

3-[7,8-bis(acetyloxy)-3a-hydroxy-9a,11a-dimethyl-5-oxo-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-(2,4-dimethyl-5-oxooxolan-3-yl)-3-hydroxybutan-2-yl acetate

C35H50O11 (646.3353)

(2s,3s,4s,5r,6r)-6-{[(1s,2s,4s,5r,6s,9s,11r,14r,15s,18s,23r)-6,10,10,14,15,21,21-heptamethyl-25-oxo-3,24-dioxaheptacyclo[16.5.2.0¹,¹⁵.0²,⁴.0⁵,¹⁴.0⁶,¹¹.0¹⁸,²³]pentacosan-9-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C36H54O10 (646.3717)

4-[10-(3,7-dimethylocta-2,6-dien-1-yl)-11-hydroxy-7-(2-hydroxypropan-2-yl)-20,20-dimethyl-13,17-dioxo-3,8,19-trioxahexacyclo[14.4.1.0²,¹⁴.0²,¹⁸.0⁴,¹².0⁵,⁹]henicosa-4(12),5(9),10,14-tetraen-18-yl]-2-methylbut-2-enoic acid

C38H46O9 (646.3142)

3,16,17-kauranetriol; (ent-3β,16βoh)-form,3,17-di-o-beta-d-glucopyranoside

C32H54O13 (646.3564)

{"Ingredient_id": "HBIN006937","Ingredient_name": "3,16,17-kauranetriol; (ent-3\u03b2,16\u03b2oh)-form,3,17-di-o-beta-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C32H54O13","Ingredient_Smile": "NA","Ingredient_weight": "646.76","OB_score": "NA","CAS_id": "64280-16-6","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8450","PubChem_id": "NA","DrugBank_id": "NA"}

3'-hydroxyaglaine b

C36H42N2O9 (646.289)

{"Ingredient_id": "HBIN008692","Ingredient_name": "3'-hydroxyaglaine b","Alias": "NA","Ingredient_formula": "C36H42N2O9","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9767","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

3'-hydroxyaglaine c

C36H42N2O9 (646.289)

{"Ingredient_id": "HBIN008693","Ingredient_name": "3'-hydroxyaglaine c","Alias": "NA","Ingredient_formula": "C36H42N2O9","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9768","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

6α-acetoxy-9β-benzoyloxy-1β-cinnamoyloxy-8β-(2-methylbutanoyloxy)-β-dihydroagaro-furan

C38H46O9 (646.3142)

{"Ingredient_id": "HBIN012194","Ingredient_name": "6\u03b1-acetoxy-9\u03b2-benzoyloxy-1\u03b2-cinnamoyloxy-8\u03b2-(2-methylbutanoyloxy)-\u03b2-dihydroagaro-furan","Alias": "NA","Ingredient_formula": "C38H46O9","Ingredient_Smile": "CCC(C)C(=O)OC1C2C(C3(C(CCC(C3(C1OC(=O)C4=CC=CC=C4)C)OC(=O)C=CC5=CC=CC=C5)C)OC2(C)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "132","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

acetylcimifugoside

C36H54O10 (646.3717)

{"Ingredient_id": "HBIN014468","Ingredient_name": "acetylcimifugoside","Alias": "NA","Ingredient_formula": "C36H54O10","Ingredient_Smile": "CC(=O)OC(C)(C)C1C2CCC3C4(CCC56CC57CCC(C(C7CC=C6C4(C(C3(O2)O1)O)C)(C)C)OC8C(C(C(CO8)O)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "352","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(2z)-4-[(1s,2s,7r,16s,18r)-10-(3,7-dimethylocta-2,6-dien-1-yl)-11-hydroxy-7-(2-hydroxypropan-2-yl)-20,20-dimethyl-13,17-dioxo-3,8,19-trioxahexacyclo[14.4.1.0²,¹⁴.0²,¹⁸.0⁴,¹².0⁵,⁹]henicosa-4(12),5(9),10,14-tetraen-18-yl]-2-methylbut-2-enoic acid

C38H46O9 (646.3142)

(2r,3r,4s,5s,6r)-2-{[(1s,2r,4as,5r,8as)-2-hydroxy-1,4a-dimethyl-5-[(3e)-3-methyl-5-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pent-3-en-1-yl]-6-methylidene-hexahydro-2h-naphthalen-1-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C32H54O13 (646.3564)

(2r,3r)-3-[(1s,3as,5ar,7r,8s,9ar,9br,11ar)-7,8-bis(acetyloxy)-3a-hydroxy-9a,11a-dimethyl-5-oxo-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-[(2s,3r,4s)-2,4-dimethyl-5-oxooxolan-3-yl]-3-hydroxybutan-2-yl acetate

C35H50O11 (646.3353)

2-[(2r,5r)-5-[(1s,4s)-4-[(2r,4ar,6r,8as)-6-[(2s,5r)-5-bromo-2,6,6-trimethyloxan-2-yl]-8a-methyl-hexahydro-2h-pyrano[3,2-b]pyran-2-yl]-1,4-dihydroxypentyl]-5-methyloxolan-2-yl]propan-2-yl acetate

C32H55BrO8 (646.308)

(2r,3r,4s,5s,6r)-2-{[(2r,3s,4as,6as,8r,10ar,10bs)-3-ethenyl-3,4a,7,7,10a-pentamethyl-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-1h-naphtho[2,1-b]pyran-8-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C32H54O13 (646.3564)

3-hydroxy-4-{[hydroxy(2-{3-hydroxy-2-[(1-hydroxy-2-methoxyethylidene)amino]-4-methylpentanoyl}-1,2-diazinan-3-yl)methylidene]amino}-n-(6-hydroxy-2-oxo-4,5-dihydro-3h-pyridin-3-yl)-2-methyl-5-phenylpentanimidic acid

C31H46N6O9 (646.3326)

methyl 3,20-diethyl-38-hydroxy-4-oxa-6,16,24,34-tetraazaundecacyclo[25.10.1.1¹³,¹⁶.0¹,²⁴.0³,²³.0⁵,¹³.0⁵,²².0⁷,¹².0²⁷,³⁵.0²⁸,³³.0²⁰,³⁹]nonatriaconta-7,9,11,18,28,30,32,35-octaene-36-carboxylate

C40H46N4O4 (646.3519)

(1s,2s,5r,6r,7s,8s,9r,12r)-12-(acetyloxy)-2,6,10,10-tetramethyl-8-{[(2r)-2-methylbutanoyl]oxy}-5-{[(2e)-3-phenylprop-2-enoyl]oxy}-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C38H46O9 (646.3142)

2-[(3-ethenyl-3,4a,7,7,10a-pentamethyl-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-1h-naphtho[2,1-b]pyran-8-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C32H54O13 (646.3564)

2-({1-[4-hydroxy-3-(2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethylidene)butyl]-1,2,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl}methoxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C32H54O13 (646.3564)

(2r,3r,4s,5s,6r)-2-{[(2s,3s,4as,6as,8r,10ar,10bs)-3-ethenyl-3,4a,7,7,10a-pentamethyl-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-1h-naphtho[2,1-b]pyran-8-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C32H54O13 (646.3564)

methyl (1s,12r,14s,18s)-12-[(1r,15s,17s,18s)-17-ethyl-7-methoxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraen-6-yl]-15-ethylidene-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate

C41H50N4O3 (646.3883)

(2s)-n-[(2s)-1-[(1r,9r,10s,11r,12r)-1,12-dihydroxy-9-(3-hydroxy-4-methoxyphenyl)-3,5-dimethoxy-10-phenyl-8-oxatricyclo[7.2.1.0²,⁷]dodeca-2,4,6-triene-11-carbonyl]pyrrolidin-2-yl]-2-methylbutanimidic acid

C36H42N2O9 (646.289)

(2r)-n-[(2s)-1-[(1r,9r,10s,11r,12s)-1,12-dihydroxy-9-(3-hydroxy-4-methoxyphenyl)-3,5-dimethoxy-10-phenyl-8-oxatricyclo[7.2.1.0²,⁷]dodeca-2,4,6-triene-11-carbonyl]pyrrolidin-2-yl]-2-methylbutanimidic acid

C36H42N2O9 (646.289)

4-[12,16-dihydroxy-8,21,21-trimethyl-5-(3-methylbut-2-en-1-yl)-8-(4-methylpent-3-en-1-yl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.0²,¹⁵.0²,¹⁹.0⁴,¹³.0⁶,¹¹]docosa-4(13),5,9,11-tetraen-19-yl]-2-methylbut-2-enoic acid

C38H46O9 (646.3142)

(3s,7r,10s,13s,17s,18r)-6,12-dihydroxy-4-(4-hydroxyphenyl)-7-(1h-indol-3-ylmethyl)-3-methoxy-8,10,13,15,17,18-hexamethyl-1-oxa-5,8,11-triazacyclooctadeca-5,11,15-triene-2,9-dione

C36H46N4O7 (646.3366)

2-{[2-hydroxy-1,4a-dimethyl-5-(3-methyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pent-3-en-1-yl)-6-methylidene-hexahydro-2h-naphthalen-1-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C32H54O13 (646.3564)

2-(5-{4-[6-(5-bromo-2,6,6-trimethyloxan-2-yl)-8a-methyl-hexahydro-2h-pyrano[3,2-b]pyran-2-yl]-1,4-dihydroxypentyl}-5-methyloxolan-2-yl)propan-2-yl acetate

C32H55BrO8 (646.308)

6,12-dihydroxy-4-(4-hydroxyphenyl)-7-(1h-indol-3-ylmethyl)-3-methoxy-8,10,13,15,17,18-hexamethyl-1-oxa-5,8,11-triazacyclooctadeca-5,11,15-triene-2,9-dione

C36H46N4O7 (646.3366)

2-[(2r,5r)-5-[(1r,4s)-4-[(2r,4as,6s,8ar)-6-[(2r,5s)-5-bromo-2,6,6-trimethyloxan-2-yl]-8a-methyl-hexahydro-2h-pyrano[3,2-b]pyran-2-yl]-1,4-dihydroxypentyl]-5-methyloxolan-2-yl]propan-2-yl acetate

C32H55BrO8 (646.308)

(1s,3r,5r,6as,7s,8s,9r,10r,10as)-1,3,10-tris(acetyloxy)-5-hydroxy-7,8-dimethyl-7-[(2e)-3-methylpenta-2,4-dien-1-yl]-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-9-yl decanoate

C36H54O10 (646.3717)

(3s,4r,7r,10s,13r,15e,17s,18s)-6,12-dihydroxy-4-(4-hydroxyphenyl)-7-(1h-indol-3-ylmethyl)-3-methoxy-8,10,13,15,17,18-hexamethyl-1-oxa-5,8,11-triazacyclooctadeca-5,11,15-triene-2,9-dione

C36H46N4O7 (646.3366)

(1s,2s,4r,5s,6s,10s,11r,12r,13r,14s,15r)-13-(acetyloxy)-5,6,11,14-tetrahydroxy-4-(hydroxymethyl)-8,12-dimethyl-7-oxo-14-(prop-1-en-2-yl)-3-oxatetracyclo[9.4.0.0²,⁴.0⁶,¹⁰]pentadec-8-en-15-yl (2e,4e)-trideca-2,4-dienoate

C35H50O11 (646.3353)

(2e)-4-[(1s,2s,8r,15s,16s,17s,19r)-12,16-dihydroxy-8,21,21-trimethyl-5-(3-methylbut-2-en-1-yl)-8-(4-methylpent-3-en-1-yl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.0²,¹⁵.0²,¹⁹.0⁴,¹³.0⁶,¹¹]docosa-4(13),5,9,11-tetraen-19-yl]-2-methylbut-2-enoic acid

C38H46O9 (646.3142)

(2s,3s,4r,5r,6s)-2-{[(1r,2s,4ar,8as)-1-[(3z)-4-hydroxy-3-(2-{[(2s,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethylidene)butyl]-1,2,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C32H54O13 (646.3564)

(2z)-4-[(1s,2s,17s,19r)-12,16-dihydroxy-8,21,21-trimethyl-5-(3-methylbut-2-en-1-yl)-8-(4-methylpent-3-en-1-yl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.0²,¹⁵.0²,¹⁹.0⁴,¹³.0⁶,¹¹]docosa-4(13),5,9,11-tetraen-19-yl]-2-methylbut-2-enoic acid

C38H46O9 (646.3142)

2-[(2r,5r)-5-[(1r)-4-[(4as,6s,8ar)-6-[(2r,5s)-5-bromo-2,6,6-trimethyloxan-2-yl]-8a-methyl-hexahydro-2h-pyrano[3,2-b]pyran-2-yl]-1,4-dihydroxypentyl]-5-methyloxolan-2-yl]propan-2-yl acetate

C32H55BrO8 (646.308)

(2s,3r,4s,5r)-2-[2,5-bis(6-chlorododecyl)-3-hydroxyphenoxy]oxane-3,4,5-triol

C35H60Cl2O6 (646.3767)

(2e)-4-[(1s,2s,7r,16s,18r)-10-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-11-hydroxy-7-(2-hydroxypropan-2-yl)-20,20-dimethyl-13,17-dioxo-3,8,19-trioxahexacyclo[14.4.1.0²,¹⁴.0²,¹⁸.0⁴,¹².0⁵,⁹]henicosa-4(12),5(9),10,14-tetraen-18-yl]-2-methylbut-2-enoic acid

C38H46O9 (646.3142)

[3,4-bis(acetyloxy)-5-hydroxy-6-[4-hydroxy-2-(11-methoxy-3,7,11-trimethyldodeca-2,6,9-trien-1-yl)-5-methylphenoxy]oxan-2-yl]methyl acetate

C35H50O11 (646.3353)

methyl (1r,12s,14s,15e)-12-[(1r,15r,17s,18s)-17-ethyl-7-methoxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraen-6-yl]-15-ethylidene-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate

C41H50N4O3 (646.3883)

(2r,3r)-3-[(1s,3as,5as,7r,8s,9ar,9br,11ar)-7,8-bis(acetyloxy)-3a-hydroxy-9a,11a-dimethyl-5-oxo-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-[(2r,3s,4s)-2,4-dimethyl-5-oxooxolan-3-yl]-3-hydroxybutan-2-yl acetate

C35H50O11 (646.3353)

2-{[(1r,2r,4ar,8as)-4a-{2-[(1r,2s,8as)-1,2,5,5-tetramethyl-2,3,6,7,8,8a-hexahydronaphthalen-1-yl]ethyl}-1,2-dimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]methyl}benzene-1,4-disulfonic acid

C36H54O6S2 (646.3362)

(1r,2r,4r,6s,8r,11r,12s,13r,16r,17r,19s,20r)-17-(acetyloxy)-8-(furan-3-yl)-12-hydroxy-4-methoxy-1,9,11,16-tetramethyl-5,14-dioxapentacyclo[11.6.1.0²,¹¹.0⁶,¹⁰.0¹⁶,²⁰]icos-9-en-19-yl (2e)-3-phenylprop-2-enoate

C38H46O9 (646.3142)

(2r)-n-[(2s)-1-[(1r,9r,10s,11r,12s)-1,12-dihydroxy-3,5-dimethoxy-9-(4-methoxyphenyl)-10-phenyl-8-oxatricyclo[7.2.1.0²,⁷]dodeca-2,4,6-triene-11-carbonyl]pyrrolidin-2-yl]-2-hydroxy-2-methylbutanimidic acid

C36H42N2O9 (646.289)

(2s,3s,4s)-3-hydroxy-n-[(3s)-6-hydroxy-2-oxo-4,5-dihydro-3h-pyridin-3-yl]-4-({hydroxy[(3s)-2-[(2r,3r)-3-hydroxy-2-[(1-hydroxy-2-methoxyethylidene)amino]-4-methylpentanoyl]-1,2-diazinan-3-yl]methylidene}amino)-2-methyl-5-phenylpentanimidic acid

C31H46N6O9 (646.3326)

2-{[8-hydroxy-1,4a-dimethyl-5-(3-methyl-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pent-3-en-1-yl)-6-methylidene-hexahydro-2h-naphthalen-1-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C32H54O13 (646.3564)

(2s)-n-[(2s)-1-[(1r,9r,10r,11s,12r)-1,12-dihydroxy-9-(3-hydroxy-4-methoxyphenyl)-3,5-dimethoxy-10-phenyl-8-oxatricyclo[7.2.1.0²,⁷]dodeca-2,4,6-triene-11-carbonyl]pyrrolidin-2-yl]-2-methylbutanimidic acid

C36H42N2O9 (646.289)

n-{1-[1,12-dihydroxy-9-(3-hydroxy-4-methoxyphenyl)-3,5-dimethoxy-10-phenyl-8-oxatricyclo[7.2.1.0²,⁷]dodeca-2,4,6-triene-11-carbonyl]pyrrolidin-2-yl}-2-methylbutanimidic acid

C36H42N2O9 (646.289)

6-{[3a-carboxy-8-formyl-5a,5b,8,11a-tetramethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C36H54O10 (646.3717)

(1s,2r,5s,6s,7s,8r,9r,12r)-12-(acetyloxy)-2,6,10,10-tetramethyl-8-{[(2r)-2-methylbutanoyl]oxy}-5-{[(2e)-3-phenylprop-2-enoyl]oxy}-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C38H46O9 (646.3142)

(1r,3r,5r,6ar,7r,8r,9s,10s,10ar)-1,3,10-tris(acetyloxy)-5-hydroxy-7,8-dimethyl-7-[(2z)-3-methylpenta-2,4-dien-1-yl]-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-9-yl decanoate

C36H54O10 (646.3717)

(2r,3r,4s,5s,6r)-2-{[(1s,2r,4as,5r,8ar)-2-hydroxy-1,4a-dimethyl-5-[(3e)-3-methyl-5-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pent-3-en-1-yl]-6-methylidene-hexahydro-2h-naphthalen-1-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C32H54O13 (646.3564)

(1s,3r,6s,7s,8r,11s,12s,16r)-7,12,16-trimethyl-15-[(1s)-1-[(2s)-5-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-6-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylic acid

C36H54O10 (646.3717)

(2s,3s,3ar,5as,5bs,9r,13s,14r,16as,16bs)-9-[(1e)-but-1-en-1-yl]-3,13-dihydroxy-4,14-dimethyl-2-{[(2s,3r,4r,5s,6s)-3,4,5-trimethoxy-6-methyloxan-2-yl]oxy}-1h,2h,3h,3ah,5ah,5bh,6h,9h,10h,11h,12h,13h,14h,16ah,16bh-as-indaceno[3,2-d]oxacyclododecane-7,15-dione

C36H54O10 (646.3717)

methyl (1s,12r,14r,15z,18r)-12-[(1r,15r,17s,18s)-17-ethyl-6-methoxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraen-5-yl]-15-ethylidene-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate

C41H50N4O3 (646.3883)

(2s,3s,4s,5r,6r)-6-{[(1r,3as,5ar,5br,7ar,8s,9s,11ar,11br,13ar,13br)-3a-carboxy-8-formyl-5a,5b,8,11a-tetramethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C36H54O10 (646.3717)

9-(but-1-en-1-yl)-3,13-dihydroxy-4,14-dimethyl-2-[(3,4,5-trimethoxy-6-methyloxan-2-yl)oxy]-1h,2h,3h,3ah,5ah,5bh,6h,9h,10h,11h,12h,13h,14h,16ah,16bh-as-indaceno[3,2-d]oxacyclododecane-7,15-dione

C36H54O10 (646.3717)

methyl (1s,12r,14s,15e,18s)-12-[(1r,15s,17s,18s)-17-ethyl-7-methoxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraen-6-yl]-15-ethylidene-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate

C41H50N4O3 (646.3883)

(2s,3s,4s,5r,6r)-6-{[(4s,4ar,6ar,6bs,8as,14ar,14br)-8a-carboxy-4-formyl-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C36H54O10 (646.3717)

(2s)-n-[(2r)-1-[(1r,9r,10r,11s,12r)-1,12-dihydroxy-3,5-dimethoxy-9-(4-methoxyphenyl)-10-phenyl-8-oxatricyclo[7.2.1.0²,⁷]dodeca-2,4,6-triene-11-carbonyl]pyrrolidin-2-yl]-2-hydroxy-2-methylbutanimidic acid

C36H42N2O9 (646.289)

(2r)-n-[(2s)-1-[(1r,9r,10r,11s,12s)-1,12-dihydroxy-9-(3-hydroxy-4-methoxyphenyl)-3,5-dimethoxy-10-phenyl-8-oxatricyclo[7.2.1.0²,⁷]dodeca-2,4,6-triene-11-carbonyl]pyrrolidin-2-yl]-2-methylbutanimidic acid

C36H42N2O9 (646.289)

12-(acetyloxy)-2,6,10,10-tetramethyl-8-[(2-methylbutanoyl)oxy]-5-[(3-phenylprop-2-enoyl)oxy]-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C38H46O9 (646.3142)

1,3,10-tris(acetyloxy)-5-hydroxy-7,8-dimethyl-7-(3-methylpenta-2,4-dien-1-yl)-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-9-yl decanoate

C36H54O10 (646.3717)

methyl 12-{17-ethyl-6-methoxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraen-5-yl}-15-ethylidene-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate

C41H50N4O3 (646.3883)

4-[12,16-dihydroxy-8,8,12,25,25-pentamethyl-5-(3-methylbut-2-en-1-yl)-18,22-dioxo-3,7,24-trioxaheptacyclo[19.4.1.0²,¹⁹.0²,²³.0⁴,¹⁷.0⁶,¹⁵.0⁹,¹⁴]hexacosa-4,6(15),16,19-tetraen-23-yl]-2-methylbut-2-enoic acid

C38H46O9 (646.3142)

(2z)-4-[(1s,2s,7r,16s,18r)-10-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-11-hydroxy-7-(2-hydroxypropan-2-yl)-20,20-dimethyl-13,17-dioxo-3,8,19-trioxahexacyclo[14.4.1.0²,¹⁴.0²,¹⁸.0⁴,¹².0⁵,⁹]henicosa-4(12),5(9),10,14-tetraen-18-yl]-2-methylbut-2-enoic acid

C38H46O9 (646.3142)

(2s)-n-[(2r)-1-[(1r,9r,10s,11r,12r)-1,12-dihydroxy-3,5-dimethoxy-9-(4-methoxyphenyl)-10-phenyl-8-oxatricyclo[7.2.1.0²,⁷]dodeca-2,4,6-triene-11-carbonyl]pyrrolidin-2-yl]-2-hydroxy-2-methylbutanimidic acid

C36H42N2O9 (646.289)

(2r,3r,4s,5s,6r)-2-{[(1s,2r,4as,8ar)-1-[(3z)-4-hydroxy-3-(2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethylidene)butyl]-1,2,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C32H54O13 (646.3564)

14-(acetyloxy)-6-(furan-3-yl)-15,16-dihydroxy-12-(2-methoxy-2-oxoethyl)-7,11,13,13-tetramethyl-4-oxo-5,17-dioxapentacyclo[13.2.1.0¹,¹⁰.0²,⁷.0¹¹,¹⁶]octadecan-18-yl 2-methylbutanoate

C34H46O12 (646.2989)

n-{1-[1,12-dihydroxy-3,5-dimethoxy-9-(4-methoxyphenyl)-10-phenyl-8-oxatricyclo[7.2.1.0²,⁷]dodeca-2,4,6-triene-11-carbonyl]pyrrolidin-2-yl}-2-hydroxy-2-methylbutanimidic acid

C36H42N2O9 (646.289)

7,12,16-trimethyl-15-[1-(5-methyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylic acid

C36H54O10 (646.3717)

(2r,3r)-3-[(1s,3as,5ar,7r,8s,9ar,9br,11ar)-7,8-bis(acetyloxy)-3a-hydroxy-9a,11a-dimethyl-5-oxo-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-[(2r,3r,4s)-2,4-dimethyl-5-oxooxolan-3-yl]-3-hydroxybutan-2-yl acetate

C35H50O11 (646.3353)

methyl (1r,12s,14s)-12-[(1r,15r,17s,18s)-17-ethyl-7-methoxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraen-6-yl]-15-ethylidene-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate

C41H50N4O3 (646.3883)

(2z)-4-[(1s,2s,9r,12r,14r,21s,23r)-12,16-dihydroxy-8,8,12,25,25-pentamethyl-5-(3-methylbut-2-en-1-yl)-18,22-dioxo-3,7,24-trioxaheptacyclo[19.4.1.0²,¹⁹.0²,²³.0⁴,¹⁷.0⁶,¹⁵.0⁹,¹⁴]hexacosa-4,6(15),16,19-tetraen-23-yl]-2-methylbut-2-enoic acid

C38H46O9 (646.3142)

(1s,3r,5r,6as,7s,8s,9r,10r,10as)-1,3,10-tris(acetyloxy)-5-hydroxy-7,8-dimethyl-7-[(2z)-3-methylpenta-2,4-dien-1-yl]-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-9-yl decanoate

C36H54O10 (646.3717)

(1s,2r,6r,7r,10r,11s,12s,14s,15s,16r,18r)-14-(acetyloxy)-6-(furan-3-yl)-15,16-dihydroxy-12-(2-methoxy-2-oxoethyl)-7,11,13,13-tetramethyl-4-oxo-5,17-dioxapentacyclo[13.2.1.0¹,¹⁰.0²,⁷.0¹¹,¹⁶]octadecan-18-yl (2r)-2-methylbutanoate

C34H46O12 (646.2989)

2-[(2r,5r)-5-[(1r,4s)-4-[(4as,6s,8ar)-6-[(2r)-5-bromo-2,6,6-trimethyloxan-2-yl]-8a-methyl-hexahydro-2h-pyrano[3,2-b]pyran-2-yl]-1,4-dihydroxypentyl]-5-methyloxolan-2-yl]propan-2-yl acetate

C32H55BrO8 (646.308)

methyl (1s,12s,14r,15e,18s)-12-[(1s,9s,12s,13s,15r,20r)-12-ethyl-8-methyl-14-oxa-8,17-diazahexacyclo[10.7.1.0¹,⁹.0²,⁷.0¹³,¹⁵.0¹⁷,²⁰]icosa-2,4,6-trien-4-yl]-15-ethylidene-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate

C41H50N4O3 (646.3883)

(1r,2r,3as,3bs,9br,11ar)-1-[(2r,4e)-2,3-dihydroxy-6-methylhepta-4,6-dien-2-yl]-2,7-dihydroxy-3a,6,9b,11a-tetramethyl-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,5h,11h-cyclopenta[a]phenanthren-10-one

C35H50O11 (646.3353)

(2e)-n-[4-({[(1s,9s,10s,11r)-1,12-dihydroxy-3,5-dimethoxy-9-(4-methoxyphenyl)-11-phenyl-8-oxatricyclo[7.2.1.0²,⁷]dodeca-2,4,6-trien-10-yl](hydroxy)methylidene}amino)butyl]-4-hydroxy-2-methylbut-2-enimidic acid

C36H42N2O9 (646.289)